PTPI - Petros Pharmaceuticals Inc Net earnings per share (EPS TTM)

Petros Pharmaceuticals (PTPI) generates revenue through the sale of over-the-counter men's health products via online services and pharmacies. The rolling net income per share chart visualizes this trend, with the indicator currently standing at -62.58. Revenues are supported by diversifying distribution outside the public sector, while the current strategic pivot aims to transition prescription drugs into the mass consumer segment.
Comprehensive metric breakdowns and analytics for Petros (PTPI)

Petros Pharmaceuticals is scaling drug sales through its own digital telemedicine platforms. This metric reflects the actual financial return per share, excluding market noise. By analyzing the one-year net income per share trend, an investor can see the actual business efficiency. The metric measures fundamental profitability regardless of speculation. Steady growth of this indicator confirms the maturity of the model and the predictability of future results.